Streetbeat News

Price Targets

SRRK

HC Wainwright & Co. analyst Andres Maldonado has reiterated a 'Buy' rating on Scholar Rock Holding (NASDAQ:SRRK) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:55 am

BYND

Mizuho analyst John Baumgartner has downgraded Beyond Meat (NASDAQ:BYND) from Neutral to Underperform and announced a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:52 am

MTNB

BTIG analyst Julian Harrison has reiterated a 'Buy' rating on Matinas BioPharma Hldgs (AMEX:MTNB) and maintained a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:52 am

VRCA

HC Wainwright & Co. analyst Oren Livnat has reiterated a 'Buy' rating on Verrica Pharmaceuticals (NASDAQ:VRCA) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:37 am

PYPD

HC Wainwright & Co. analyst Raghuram Selvaraju has initiated coverage on PolyPid (NASDAQ:PYPD) with a Buy rating and a price target of $16.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:34 am

RPHM

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a 'Buy' rating on Reneo Pharmaceuticals (NASDAQ:RPHM) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:26 am

EXK

HC Wainwright & Co. analyst Heiko Ihle has reiterated a 'Buy' rating on Endeavour Silver (NYSE:EXK) and maintained a price target of $7.75.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:24 am

PL

Needham analyst Ryan Koontz has reiterated a 'Buy' rating on Planet Labs (NYSE:PL) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:19 am

RVMD

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Revolution Medicines (NASDAQ:RVMD) and maintained a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:17 am

VAC

JP Morgan analyst Ryan Lambert has initiated coverage on Marriott Vacations (NYSE:VAC) with a Neutral rating and a price target of $105.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 9:51 am